An open trial evaluation of the BDZ (information and reduction) digital health program for people using benzodiazepines.

Not Applicable

• Conditions: Benzodiazepine dependency; Mental Health - Addiction; Mental Health - Anxiety

• Registration Number: ACTRN12617000574347
• Lead Sponsor: Federation University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-24
• Study Completion: 2022-04-15
• Last Update Posted: 15 August 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

Participants must be 18 years or older, currently using benzodiazepines, have access to the internet, provide consent, and be able to register online using an email address.

Exclusion Criteria

Participants must not be residing overseas, do not have a current untreated and severe (psychotic) illness, nor will they be using the ‘cold turkey’ method to reduce their benzodiazepine intake during the study (i.e., complete withdrawal from their benzodiazepines).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Benzodiazepine dependency will be measured by the BDQ.[Pre-intervention (Week 0), post-intervention (Week 6), 3 month (Week 18), 6 month follow-up (Week 30) assessment.];Self-reported benzodiazepine medication use via online questions (Type & Dose)[Pre-intervention, post intervention and 3 and 6 month follow-up]